US equities
|
NVDA
$238.90
▲+2.12%
SPCX
$171.09
▲+7.63%
MU
$1,063.89
▼-1.02%
TSLA
$378.69
▲+2.18%
WBD
$30.95
▲+0.03%
MSFT
$525.18
▲+1.48%
SNDK
$1,704.16
▼-0.92%
AAPL
$332.89
▼-0.24%
NVDA
$238.90
▲+2.12%
SPCX
$171.09
▲+7.63%
MU
$1,063.89
▼-1.02%
TSLA
$378.69
▲+2.18%
WBD
$30.95
▲+0.03%
MSFT
$525.18
▲+1.48%
SNDK
$1,704.16
▼-0.92%
AAPL
$332.89
▼-0.24%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Sunshine Biopharma Inc. - Common stock
(NQ:
SBFM
)
0.4201
-0.2464 (-36.97%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Sunshine Biopharma Inc. - Common stock
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
SUNSHINE BIOPHARMA ANNOUNCES PUBLICATION OF SIGNIFICANT CORONAVIRUS RESEARCH RESULTS IN THE JOURNAL OF MEDICINAL CHEMISTRY
September 04, 2024
Current Test Positivity Rate for Coronavirus Infection in the U.S. is 18% Development of a novel antiviral compound, XR8-23 (Compound 10), targeting SARS-CoV-2 papain-like protease (PLpro) with both...
Via
FinancialNewsMedia
Sunshine Biopharma Announces Publication of Significant Coronavirus Research Results in the Journal of Medicinal Chemistry
September 04, 2024
Via
ACCESSWIRE
Sunshine Biopharma Has Launched Nine New Generic Prescription Drugs in 2024: Now Marketing Sixty-One Generic Drugs in Canada
August 26, 2024
Via
ACCESSWIRE
Sunshine Biopharma Reports 2024 Second Quarter Results: Second QTR Revenues up 67%, YTD Revenues up 61%
August 19, 2024
Via
ACCESSWIRE
SBFM Stock Earnings: Sunshine Biopharma Misses EPS, Beats Revenue for Q2 2024
↗
August 16, 2024
SBFM stock results show that Sunshine Biopharma missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Sunshine Biopharma Announces Reverse Stock Split
August 06, 2024
Via
ACCESSWIRE
7 F-Rated Growth Stocks to Avoid Right Now: June 2024
↗
June 28, 2024
A good rating for growth in the Portfolio Grader doesn't tell the full picture. These are all growth stocks to avoid now.
Via
InvestorPlace
3 Penny Stocks Ready to Explode Into Dollar Signs by 2028
↗
June 20, 2024
The best penny stocks to buy are those you can understand and stomach the exceptional risks of in order to profit.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
June 19, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
June 18, 2024
Via
Benzinga
Why Skye Bioscience Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
June 10, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
June 10, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
June 10, 2024
Via
Benzinga
Why KKR Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket
↗
June 10, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
↗
June 07, 2024
Via
Benzinga
Sunshine Biopharma Reports 2024 First Quarter Results: Revenues Up 54%
May 21, 2024
Via
ACCESSWIRE
SBFM Stock Earnings: Sunshine Biopharma Beats EPS, Beats Revenue for Q1 2024
↗
May 20, 2024
SBFM stock results show that Sunshine Biopharma beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
3 Meme Stocks to Sell That Even Roaring Kitty Can’t Save
↗
May 16, 2024
Looking for the best meme stocks to sell after the Roaring Kitty rally? These three struggling companies seem to be beyond hope.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
May 14, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
May 06, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
April 26, 2024
Via
Benzinga
Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
↗
April 26, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
April 25, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
April 24, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
April 23, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
April 23, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
↗
April 23, 2024
We're diving into the biggest pre-market stock movers that traders are going to want to keep an eye on for Tuesday morning!
Via
InvestorPlace
Why Vaxxinity Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
April 22, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
April 22, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
↗
April 22, 2024
It's time to start ofd the trading week with a look at the biggest pre-market stock movers traders need to watch on Monday morning!
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >